BackPacific Biosciences of California Overview
Pacific Biosciences of California Inc

Pacific Biosciences of California Target Price

Where could PACB trade next? Consensus target price: $1.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.15

Average Target Price

$1.0013% downside

1 analysts in the last 4 months

High: $1 | Low: $1

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-14Barclays$113% downsideOpen
2025-08-08BernsteinEve Burstein$1.747.8% upsideOpen
2025-06-25BarclaysLuke Sergott$1.530.4% upsideOpen
2024-06-03JefferiesTycho Peterson$4247.8% upsideOpen
2024-05-13Morgan StanleyTejas Savant$4247.8% upsideOpen
2024-05-13Piper SandlerDavid Westenberg$273.9% upsideOpen
2024-05-10BarclaysLuke Sergott$273.9% upsideOpen
2024-04-18Goldman SachsMatthew Sykes$2.5117.4% upsideOpen
2024-04-16Canaccord GenuityKyle Mikson$3.5204.3% upsideOpen
2022-11-16Canaccord Genuity$141117.4% upsideOpen
2022-08-17Piper SandlerDavid Westenberg$7.5552.2% upsideOpen
2022-05-15Piper SandlerDavid Westenberg$6421.7% upsideOpen
2022-01-12Piper SandlerDavid Westenberg$201639.1% upsideOpen

Pacific Biosciences of California (PACB) FAQ

As of the most recent data, PACB shows a target price of $1. Scroll down for historical charts and peer comparison views.

If Pacific Biosciences of California moved to the average analyst target of $1, shares would be roughly 13.0% lower than $1.15. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Pacific Biosciences of California's earnings trajectory.

Besides this target price page, Stockcircle has Pacific Biosciences of California's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $1) with ownership activity and broader fundamentals.

Pacific Biosciences of California's target price is $1; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.